Wine: Does the colour count?

Clinica Chimica Acta

Volumn 246, Issue 1-2, 1996, Pages 183-193

  Goldberg, David M ^a   Garovic Kocic, Vesna ^a   Diamandis, Eleftherios P ^a   Pace Asciak, Cecil R ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Coronary heart disease; Flavonoids; HDL cholesterol; Lipoproteins; Plasma lipids; Polyphenols; Wine

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FRUIT JUICE; HUMAN; HUMAN EXPERIMENT; LIPID METABOLISM; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WINE;

EID: 0029926065     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06229-8     Document Type: Conference Paper

References (41)

1. Jackson R, Scragg R, Beaglehole R. Alcohol consumption and risk of coronary heart disease. Br Med J 1991;303:211-216.
2. Klatsky AL, Armstrong MA, Friedman GD. Alcohol and mortality. Ann Intern Med 1992;117:646-654.
3. Doll R, Peto R, Hall E, Wheatley K, Gray R. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. Br Med J 1994;309:911-918.
4. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992;85:910-915.
5. Suh I, Shaten J, Cutler JA, Kuller LH. Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. Ann Intern Med 1992;116:881-887.
6. Gaziano JM, Buring JE, Breslow JL, Goldhaber SZ, Rosner B, Van Denburgh BA, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-1834.
7. Renaud S, De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339:1523-1526.
8. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet 1994;344:1719-1723.
9. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb et Zucc. on lipid metabolism. Chem Pharm Bull 1982;30:1766-1779.
10. Kimura Y, Ohminami H, Okuda H, Baba K, Kozawa M, Arichi S. Effects of stilbene components of roots of Polygonum sso. on liver injury in peroxidized oil-fed rats. Plant Res 1983;49:51-54.
11. Goldberg DM, Yan J, Ng E, Diamandis EP, Karumanchiri A, Soleas G, Waterhouse AL. Direct injection gas chromatographic mass spectrometric assay for trans-resveratrol. Anal Chem 1994;66:3959-3963.
12. Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 1996; 246:163-182.
13. Rifai N, Warnick GR. Laboratory measurement of lipids, lipoproteins and apolipoproteins. Washington DC: AACC Press, 1994.
14. Schneider J, Liesenfeld A, Mordasini R, Schubotz R, Zofel P, Kubel F, et al. Lipoprotein fractions, lipoprotein lipase and hepatic triglyceride lipase during short-term and long-term uptake of ethanol in healthy subjects. Atherosclerosis 1985;57:281-291.
15. Valimaki M, Laitinen K, Ylikahri R, Ehnholm C, Jauhiainen M, Bard JM, et al. The effect of moderate alcohol intake on serum apolipoprotein A-I-containing lipoproteins and lipoprotein (a). Metabolism 1991;40:1168-1172.
16. Frimpong NA, Lapp JA. Effects of moderate alcohol intake in fixed or variable amounts on concentration of serum lipids and liver enzymes in healthy young men. Am J Clin Nutr 1989;50:987-991.
17. Burr ML, Fehily AM, Butland BK, Bolton CH, Eastham RD. Alcohol and high-density-lipoprotein cholesterol: a randomized controlled trial. Br J Nutr 1986;56:81-86.
18. Moore RD, Smith CR, Kwiterovich PO, Pearson TA. Effect of low-dose alcohol use versus abstention on apolipoproteins A-I and B. Am J Med 1988;84:884-890.
19. Barboriak JJ, Alaupovic P, Cushman P. Abstinence-induced changes in plasma apolipoprotein levels of alcoholics. Drug Alcohol Depend 1981;8:337-343.
20. La Porte R, Valvo-Gerard L, Kuller L, Dai W, Bates M, Cresanta J, et al. The relationship between alcohol consumption, liver enzymes and high-density lipoprotein cholesterol. Circulation 1981;64:67-72.
21. Taskinen M-R, Valimaki M, Nikkila EA, Kuusi T, Ehnholm C, Ylikahri R. High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after ethanol withdrawal. Metabolism 1982;31:1168-1174.
22. Tateossian S, Peynet JG, Legrand AG, Collet B, Rossignol JA, Delattre JJ, et al. Variations in HDL and VLDL levels of chronic alcoholics. Influence of the degree of liver damage and of withdrawal of alcohol. Clin Chim Acta 1985;148:211-219.
23. Hartung GH, Foreyt JP, Mitchell RE, Mitchell JG, Reeves RC, Gotto AM Jr. Effect of alcohol intake on high-density lipoprotein cholesterol levels in runners and inactive men. J Am Med Assoc 1983;249:747-750.
24. Fraser GE, Anderson JT, Foster N, Goldberg R, Jacobs D, Blackburn H. The effect of alcohol on serum high density lipoprotein (HDL). Atherosclerosis 1983;46:275-288.
25. Couzigou P, Fleury B, Crockett R, Rautou JJ, Blanchard P, Lemoine F, et al. High density lipoprotein cholesterol and apoprotein Al in healthy volunteers during long-term moderate alcohol intake. Ann Nutr Metab 1984;28:377-384.
26. Malmendier CL, Delcroix C. Effect of alcohol intake on high and low density lipoprotein metabolism in healthy volunteers. Clin Chim Acta 1985;152:281-288.
27. Camargo CA Jr, Williams PT, Vranizan KM, Albers JJ, Wood PD. The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II. J Am Med Assoc 1985;253:2854-2857.
28. Valimaki M, Taskinen M-R, Ylikahri R, Roine R, Kuusi T, Nikkila EA. Comparison of the effects of two different doses of alcohol on serum lipoproteins, HDL-subfractions and apolipoproteins A-I and A-II: a controlled study. Eur J Clin Invest 1988;18:472-480.
29. Seigneur M, Bonnet J, Dorian B, Benchimol D, Drouillet F, Gouveneur G et al. Effect of the consumption of alcohol, white wine, and red wine on platelet function and serum lipids. J Appl Cardiol 1990;5:215-222.
30. Klurfeld DM, Kritchevsky D. Differential effects of alcoholic beverages on experimental atherosclerosis in rabbits. Exp Mol Pathol 1981;34:62-71.
31. Frankel EN, Kanner J, German JB, Parks, E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-457.
32. Maxwell S, Cruickshank A, Thorpe G. Red wine and antioxidant activity in serum. Lancet 1994;344:193-194.
33. Whitehead TP, Robinson D, Allaway S, Syms J, Hale A Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem 1995;41:32-35.
34. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994;344:793-795.
35. Kimura Y, Okuda H, Arichi S. Effects of stilbenes on arachidonate metabolism in leukocytes. Biochim Biophys Acta 1985;834:275-278.
36. Chung M-I, Teng C-M, Cheng K-L, Ko F-N, Lin C-N. An antiplatelet principle of Veratrum formosanum. Planta Med 1992;58:274-276.
37. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995;235:207-219.
38. Yugarani T, Tan BKH, Teh M, Das NP. Effects of polyphenolic natural products on the lipid profiles of rats fed high fat diets. Lipids 1992;27:181-186.
39. Tebib K, Bitri L, Besancon P, Rouanet J-M. Polymeric grape seed tannins prevent plasma cholesterol changes in high-cholesterol-fed rats. Food Chem 1994;49:403-406.
40. Klatsky AL, Armstrong MA. Alcoholic beverage choice and risk of coronary artery disease mortality: Do red wine drinkers fare best? Am J Cardiol 1993;71:467-469.
41. Grönbaek M, Deis A, Sörensen TIA, Becker U, Schnohr P, Jensen G. Mortality associated with moderate intakes of wine, beer, or spirits. Br Med J 1995;310:1165-1169.